Geisinger Medical Oncology at Evangelical Community Hospital
Lewisburg, Pennsylvania, United States
About Geisinger Medical Oncology at Evangelical Community Hospital
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
ECOG-ACRIN Cancer Research Group
4
Eastern Cooperative Oncology Group
1
SWOG Cancer Research Network
1
Clinical Trials at Geisinger Medical Oncology at Evangelical Community Hospital
During the past decade, Geisinger Medical Oncology at Evangelical Community Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on
average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence
Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer
2015-04-01
2022-05-10
Completed
36
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Geisinger Medical Oncology at Evangelical Community Hospital"
#1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Geisinger Medical Oncology at Evangelical Community Hospital
According to Clinical.Site data, the most researched conditions in "Geisinger Medical Oncology at Evangelical Community Hospital" are
"Lymphoma" (2 trials), "Gastrinoma" (1 trials), "Glucagonoma" (1 trials), "Head and Neck Squamous Cell Carcinoma" (1 trials) and "High Grade Upper Tract Urothelial Carcinoma" (1 trials). Many other conditions were trialed in "Geisinger Medical Oncology at Evangelical Community Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Geisinger Medical Oncology at Evangelical Community Hospital
Most popular intervention types in "Geisinger Medical Oncology at Evangelical Community Hospital" are "Drug" (6 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "bortezomib" (2 trials), "lenalidomide" (2 trials), "placebo" (2 trials), "rituximab" (2 trials) and "Bendamustin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Geisinger Medical Oncology at Evangelical Community Hospital
The vast majority of trials in "Geisinger Medical Oncology at Evangelical Community Hospital" are
6 trials for "All" genders.
Clinical Trials Status at Geisinger Medical Oncology at Evangelical Community Hospital
Currently, there are NaN active trials in "Geisinger Medical Oncology at Evangelical Community Hospital".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Geisinger Medical Oncology at Evangelical Community Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Geisinger Medical Oncology at Evangelical Community Hospital, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".